← Back to Search

Procedure

Ultraviolet Light Therapy for Lupus

Phase 2

Waitlist Available

Research Sponsored by National Center for Research Resources (NCRR)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients ages 15 to 70 with symptomatic systemic lupus erythematosus meeting American Rheumatism Association criteria and normal controls

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will study the effects of ultraviolet A-1 light therapy in patients with lupus.

Who is the study for?

This trial is for individuals aged 15 to 70 who have symptoms of systemic lupus erythematosus and meet specific criteria set by the American Rheumatism Association. People taking tetracycline or other drugs that increase sensitivity to light cannot participate.Check my eligibility

What is being tested?

The study is looking at how ultraviolet A-1 (UVA-1) light therapy affects those with systemic lupus erythematosus compared to people without the disease, aiming to understand the underlying mechanisms of this treatment.See study design

What are the potential side effects?

Potential side effects may include skin reactions like redness or irritation from UVA-1 exposure. Since it's a form of light therapy, there might also be risks related to eye damage if proper protection isn't used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 15 and 70 years old with diagnosed lupus.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Center for Research Resources (NCRR)Lead Sponsor

537 Previous Clinical Trials

316,996 Total Patients Enrolled

Louisiana State University Health Sciences Center in New OrleansOTHER

114 Previous Clinical Trials

44,181 Total Patients Enrolled

Hugh McGrath, Jr.Study ChairLouisiana State University Health Sciences Center in New Orleans

Media Library

Ultraviolet Light Therapy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT00004375 — Phase 2

Lupus Clinical Trial 2023: Ultraviolet Light Therapy Highlights & Side Effects. Trial Name: NCT00004375 — Phase 2

Ultraviolet Light Therapy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00004375 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is qualified to partake in this clinical investigation?

"This medical study is recruiting up to 20 participants afflicted with lupus erythematosus, systemic who are between 15 and 70 years of age."

Answered by AI

Are there currently opportunities to join this medical experiment?

"The facts found on clinicaltrials.gov validate that this trial is no longer seeking participants, having first been published in September of 1991 and last amended in June 2005. At present, there are 124 other studies actively recruiting patients."

Answered by AI

Is this experiment inclusive of individuals aged 18 and over?

"Patients aged between 15 and 70 are eligible to participate in this medical trial."

Answered by AI

What risks do patients face when undergoing this treatment?

"Our medical team has classified this treatment's safety as a 2. This is because, while there are some findings indicating the drug's security, there is an absence of evidence vouching for its efficacy during Phase 2 trials."

Answered by AI

Recent research and studies

LupusJournal

Review : Ultraviolet-a1 (340-400 Nm) Irradiation Therapy in Systemic Lupus Erythematosus

McGrath, H., JR, P. Martínez-Osuna, and FA Lee. 1996. “Review : Ultraviolet-a1 (340-400 Nm) Irradiation Therapy in Systemic Lupus Erythematosus”. Lupus. SAGE Publications. doi:10.1177/096120339600500405.

clinicaltrials.govStudy

Ultraviolet Light Therapy for Systemic Lupus Erythematosus

1991. "Ultraviolet Light Therapy for Systemic Lupus Erythematosus". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00004375.

All > Systemic Lupus Erythematosus > Ic